The significant increase in pERK in NB21 offspring in both models may reflect a general decrease in myocyte cell number in utero due to maternal hyperglycemia that is compensated for by an increase in pERK-driven myocyte proliferation postnatally. The gene discussed is EIF2AK3; the disease is Hyperglycemia.